HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trastuzumab in inflammatory breast cancer.

AuthorsR S Mehta, T Schubbert, K Kong
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 19 Issue 10 Pg. 1815-7 (Oct 2008) ISSN: 1569-8041 [Electronic] England
PMID18711028 (Publication Type: Letter, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • cremophor
  • Polyethylene Glycols
  • Doxorubicin
  • Cyclophosphamide
  • Trastuzumab
  • Paclitaxel
Topics
  • Antibodies, Monoclonal (administration & dosage)
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Breast Neoplasms (drug therapy, pathology, surgery)
  • Combined Modality Therapy
  • Cyclophosphamide (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Humans
  • Inflammation (pathology)
  • Paclitaxel (administration & dosage)
  • Polyethylene Glycols (administration & dosage)
  • Trastuzumab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: